CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer
<h4>Purpose</h4> The International Federation of Gynecology and Obstetrics (FIGO) stage remains the standard staging system for the assessment of endometrial cancer (EC) prognosis. Thus, we aim to identify the significant genes or biomarkers associated with the stage of endometrial cance...
Main Authors: | Yaping Wang, Shujun Zhao, Qiaohong Qin, Xiang Gao, Xinlu Zhang, Min Zhang, Yi Jiang, Xiaorong Ji, Hai Zhu, Xin Zhao, Hongyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789190/?tool=EBI |
Similar Items
-
Prognostic value of mitochondrial CKMT2 in Pan-cancer and its tumor immune correlation analysis
by: Wei Lin, et al.
Published: (2024-01-01) -
Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network
by: Ming-Jun Zheng, et al.
Published: (2018-12-01) -
An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer
by: Yonghui Yu, et al.
Published: (2023-09-01) -
KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
by: Kang He, et al.
Published: (2023-01-01) -
Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
by: Eva Coll-de la Rubia, et al.
Published: (2020-06-01)